Minimal metastatic disease

Journal of Clinical Pathology

Volumn 57, Issue 1, 2004, Pages 21-

  Reid, M M ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER RISK; CHROMOSOME ANALYSIS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; EDITORIAL; GENETIC RISK; HUMAN; IMMUNOLOGICAL TECHNIQUE; MINIMAL RESIDUAL DISEASE; NEUROBLASTOMA; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

BONE MARROW NEOPLASMS; CHILD; HUMANS; NEOPLASM CIRCULATING CELLS; NEUROBLASTOMA;

EID: 0347125131     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.57.1.21     Document Type: Editorial

References (5)

1. Burchill SA. Micrometastases in neuroblastoma: are they clinically important? J Clin Pathol 2004;57:14-20.
2. Reid MM. Detection of marrow infiltration by neuroblastoma in clinical practice: how far have we come? Eur J Cancer 1994;30A:134-5.
3. Méhes G, Luegmayr A, Ambros IM, et al. Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow. Clin Cancer Res 2001;7:1969-75.
4. Moppet J, Burke GAA, Steward CG, et al. The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. J Clin Pathol 2003;56:249-53.
5. Donadieu J, Hill C. Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review. Br J Haematol 2001;115:34-45.